You are viewing an incomplete version of our website. Please click to reload the website as full version.

ILP-2 (N-Term) Peptide

Details for Product No. ABIN1382114, Supplier: Log in to see
Protein Name
  • ILP-2
  • ILP2
  • hILP2
Protein Region
N-Term
Origin
Human
Application
Blocking Peptide (BP)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Blocked Antibody anti-ILP-2 (N-Term) antibody (ABIN1031417)
Characteristics 12 amino amino terminus of human ILP-2.
Human
Research Area Apoptosis/Necrosis
Application Notes ILP-2 peptide is used for blocking the. activity of ILP-2.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Richter, Mir, Eiben et al.: "Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family." in: Molecular and cellular biology, Vol. 21, Issue 13, pp. 4292-301, 2001 (PubMed).

Ogura, Bonen, Inohara et al.: "A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease." in: Nature, Vol. 411, Issue 6837, pp. 603-6, 2001 (PubMed).

Hugot, Chamaillard, Zouali et al.: "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease." in: Nature, Vol. 411, Issue 6837, pp. 599-603, 2001 (PubMed).